EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease

Lauren G Russell, Maria Kolatsi-Joannou, Laura Wilson, Jennifer C Chandler, Nuria Perretta Tejedor, Georgie Stagg, Karen L Price, Christopher J Rowan, Tessa Crompton, Norman D Rosenblum, Paul J D Winyard, David A Long iD

Physiological Reports · 2025

DOI: 10.14814/phy2.70191 ↗

At a glance

Journal article in Physiological Reports, 2025. Written by Lauren G Russell and 11 co-authors. Institution: Developmental Biology and Cancer Research and Teaching Department, University College London, Great Ormond Street Institute of Child Health, London, …. Major MEDLINE topics: Zinc Finger Protein Gli3, Polycystic Kidney, Autosomal Recessive, Nerve Tissue Proteins, Kruppel-Like Transcription Factors. Cited 2 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), Wellcome Trust (WT), Kidney Research UK.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Polycystic kidney diseases (PKD) are genetic disorders which disrupt kidney architecture and function. Autosomal recessive PKD (ARPKD) is a rare form of PKD, caused by mutations in PKHD1 , and clinically more severe than the more common autosomal dominant PKD (ADPKD). Prior studies have implicated Hedgehog (Hh) signaling in ADPKD, with increased levels of Hh components in experimental ADPKD and reduced cystogenesis following pharmacological Hh inhibition. In contrast, the role of the Hh pathway in ARPKD is poorly understood. We hypothesized that Hh pathway activity would be elevated during ARPKD pathogenesis, and its modulation may slow disease progression. We utilized Cpk mice which phenocopy ARPKD and generated a PKHD1 ‐mutant spheroid model in human collecting ducts. Significantly elevated levels of the Hh transcriptional effector Gli3 were found in Cpk mice, a finding replicated in PKHD1 ‐mutant spheroids. In Cpk mice, total GLI3 and GLI3 repressor protein levels were also increased. Reduction of increased Gli3 levels via heterozygous genetic deletion in Cpk mice did not affect cyst formation. Additionally, lowering GLI3 transcripts to wildtype levels did not influence PKHD1 ‐mutant spheroid size. Collectively, these data suggest attenuation of elevated Gli3 does not modulate murine and human models of ARPKD.

Subjects

MeSH terms (MEDLINE)

Zinc Finger Protein Gli3Polycystic Kidney, Autosomal RecessiveNerve Tissue ProteinsKruppel-Like Transcription FactorsAnimalsMiceHumansDisease ProgressionReceptors, Cell SurfaceDisease Models, AnimalMaleSignal TransductionMice, Inbred C57BL

Author keywords

autosomal recessive polycystic kidney diseasecystogenesishedgehog signalinghuman modelmouse model

Substances

Zinc Finger Protein Gli3Gli3 protein, mouseNerve Tissue ProteinsReceptors, Cell SurfacePkhd1 protein, mouseGLI3 protein, humanKruppel-Like Transcription Factors

Authors and institutions

  • Developmental Biology and Cancer Research and Teaching Department, University College London, Great Ormond Street Institute of Child Health, London, UK.
  • UCL Centre for Kidney and Bladder Health, University College London, London, UK.
  • Department of Paediatrics, Program in Developmental and Stem Cell Biology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Infection, Immunity and Inflammation Research and Teaching Department, University College London, Great Ormond Street Institute of Child Health, London, UK.

ORCID profiles: David A Long

Funding

  • UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
  • Wellcome Trust (WT)
  • Kidney Research UK
  • NIHR | NIHR Great Ormond Street Hospital Biomedical Research Centre (BRC)
  • University College London Research Culture Award
  • Gouvernement du Canada | Canadian Institutes of Health Research (IRSC)
  • Biotechnology and Biological Sciences Research Council
  • NIHR Great Ormond Street Hospital Biomedical Research Centre

Cite

APA

Russell, L. G., Kolatsi-Joannou, M., Wilson, L., Chandler, J. C., Tejedor, N. P., Stagg, G., Price, K. L., Rowan, C. J., Crompton, T., Rosenblum, N. D., Winyard, P. J. D., & Long, D. A. (2025). Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease. Physiological Reports. https://doi.org/10.14814/phy2.70191

Vancouver

Russell LG, Kolatsi-Joannou M, Wilson L, Chandler JC, Tejedor NP, Stagg G, et al. Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease. Physiological Reports. 2025. doi:10.14814/phy2.70191

BibTeX
@article{Russell2025,
  author = {Russell, Lauren G and Kolatsi-Joannou, Maria and Wilson, Laura and Chandler, Jennifer C and Tejedor, Nuria Perretta and Stagg, Georgie and Price, Karen L and Rowan, Christopher J and Crompton, Tessa and Rosenblum, Norman D and Winyard, Paul J D and Long, David A},
  title = {Reduction of elevated Gli3 does not alter the progression of autosomal recessive polycystic kidney disease},
  journal = {Physiological Reports},
  year = {2025},
  doi = {10.14814/phy2.70191}
}
Start for free →